| Primary |
| Attention Deficit/hyperactivity Disorder |
43.8% |
| Insomnia |
12.5% |
| Abnormal Behaviour |
9.4% |
| Accidental Overdose |
6.3% |
| Accidental Exposure To Product By Child |
3.1% |
| Adhd |
3.1% |
| Aggression |
3.1% |
| Anxiety |
3.1% |
| Autism |
3.1% |
| Autism Spectrum Disorder |
3.1% |
| Hypertension |
3.1% |
| Nightmare |
3.1% |
| Overdose |
3.1% |
|
| Blood Pressure Decreased |
9.1% |
| Formication |
9.1% |
| Anaphylactic Reaction |
4.5% |
| Anxiety |
4.5% |
| Coeliac Disease |
4.5% |
| Diabetes Mellitus Inadequate Control |
4.5% |
| Feeling Abnormal |
4.5% |
| Feeling Cold |
4.5% |
| Hallucination |
4.5% |
| Irritability |
4.5% |
| Lethargy |
4.5% |
| Medication Error |
4.5% |
| Migraine With Aura |
4.5% |
| Overdose |
4.5% |
| Product Quality Issue |
4.5% |
| Rash |
4.5% |
| Sleep Terror |
4.5% |
| Suicidal Ideation |
4.5% |
| Swelling Face |
4.5% |
| Tachycardia |
4.5% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
30.0% |
| Abnormal Behaviour |
11.3% |
| Insomnia |
11.3% |
| Aggression |
10.0% |
| Autism |
8.8% |
| Autism Spectrum Disorder |
8.8% |
| Accidental Overdose |
7.5% |
| Asthma |
5.0% |
| Bipolar Disorder |
2.5% |
| Adhd |
1.3% |
| Impulsive Behaviour |
1.3% |
| Overdose |
1.3% |
| Product Used For Unknown Indication |
1.3% |
|
| Blood Pressure Decreased |
25.0% |
| Irritability |
18.8% |
| Coeliac Disease |
9.4% |
| Lethargy |
9.4% |
| Tachycardia |
9.4% |
| Cardiac Fibrillation |
3.1% |
| Completed Suicide |
3.1% |
| Exposure Via Ingestion |
3.1% |
| Hallucination |
3.1% |
| Nephrotic Syndrome |
3.1% |
| Overdose |
3.1% |
| Swelling Face |
3.1% |
| Torticollis |
3.1% |
| Trismus |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.8% |
| Attention Deficit/hyperactivity Disorder |
11.8% |
| Hypertension |
11.4% |
| Blood Cholesterol Increased |
3.1% |
| Diabetes Mellitus |
3.1% |
| Hepatitis C |
3.1% |
| Insomnia |
3.1% |
| Sleep Disorder |
3.1% |
| Depression |
2.8% |
| Drug Use For Unknown Indication |
2.8% |
| Anxiety |
2.0% |
| Atrial Fibrillation |
2.0% |
| Blood Pressure |
2.0% |
| Growth Hormone Deficiency |
2.0% |
| Pain |
2.0% |
| Affective Disorder |
1.6% |
| Bipolar I Disorder |
1.6% |
| Blood Triglycerides Increased |
1.6% |
| Gastric Disorder |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
|
| Granulocytopenia |
12.2% |
| Weight Increased |
12.2% |
| Drug Ineffective |
6.1% |
| Injection Site Pain |
6.1% |
| Weight Decreased |
6.1% |
| Wrong Technique In Drug Usage Process |
6.1% |
| Application Site Pruritus |
4.1% |
| Cerebrovascular Accident |
4.1% |
| Drug Administration Error |
4.1% |
| Flushing |
4.1% |
| Menopause |
4.1% |
| Off Label Use |
4.1% |
| Product Quality Issue |
4.1% |
| Sensory Disturbance |
4.1% |
| Streptococcal Infection |
4.1% |
| Tremor |
4.1% |
| Vomiting |
4.1% |
| Abdominal Pain |
2.0% |
| Acute Respiratory Distress Syndrome |
2.0% |
| Anxiety |
2.0% |
|
